Menu Back toWelcome-and-Opening-Remarks

DIA/FDA Advancing Complex Innovative Clinical Trial Designs to Efficiently Deliver Medicines to Patients

Welcome and Opening Remarks

Session Chair(s)

Bill  Allman

Bill Allman

  • Chief Digital Officer
  • DIA, United States
Robert A. Beckman, MD

Robert A. Beckman, MD

  • Professor of Oncology, Bioinformatics, and Biomathematics
  • Georgetown University Medical Center, United States
Fanni  Natanegara, PhD

Fanni Natanegara, PhD

  • Senior Director - Statistics
  • Eli Lilly and Company, United States
Cartier  Esham, PhD, MSc

Cartier Esham, PhD, MSc

  • Chief Scientific Officer
  • Biotechnology Innovation Organization (BIO), United States


Richard  Moscicki, MD


Richard Moscicki, MD

  • Chief Medical Officer and Executive Vice President, Science and Regulatory
  • PhRMA, United States

Contact us

Registration Questions?

Send Email

Additional Information

Complex Innovative Clinical Trial Designs Resource Kit

View Infographic

On Demand Content Preview Webinar

Recent Regulatory Efforts on Complex Innovative Clinical Trial Design
Register Today!